{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:51:20Z","timestamp":1793663480764,"version":"4.5.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The impact of co-infection with other pathogenic microorganisms after initiation of treatment for <jats:italic>Mycobacterium avium<\/jats:italic> complex pulmonary disease (MAC-PD) has not been clearly described. This study sought to clarify the clinical outcomes of co-infection with MAC after antimycobacterial therapy for MAC.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Co-infection status was defined as the detection of pathogenic microorganisms other than MAC in at least two consecutive sputum cultures 6\u201324\u00a0months after initiation of treatment. Chest computed tomography (CT) findings and culture results were compared between co-infection and MAC alone groups.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The co-infection and MAC alone groups comprised 12 and 36 patients, respectively. The proportion of patients with sputum culture positive for MAC after 24\u00a0months of therapy did not differ significantly between the two groups [25% (3\/12) vs. 16.7% (6\/36); <jats:italic>p<\/jats:italic>\u2009=\u20090.671]. The proportion of patients with improved chest CT score after 24\u00a0months of starting treatment compared to baseline was significantly lower for the co-infection group than for the MAC alone group [16.7% (2\/12) vs. 79.4% (27\/34); <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001]. In the co-infection group, median CT score values at 12 and 24\u00a0months did not differ from baseline. However, the MAC alone group showed significant improvement at 12 and 24\u00a0months compared with baseline.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In the patient group with co-infection of other pathogenic microorganisms after treatment initiation for MAC there was no impact on therapeutic efficacy compared to the MAC alone group. However, therapeutic intervention interfered with improvement in chest CT findings such as nodule formation, bronchiectasis, infiltration, and cavitary lesions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-022-01947-7","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T10:04:24Z","timestamp":1650881064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Impact of chronic co-infection in pulmonary Mycobacterium avium complex disease after treatment initiation"],"prefix":"10.1186","volume":"22","author":[{"given":"Naohisa","family":"Urabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Shimanuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kanokogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Motohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanami","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Tokita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakae","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"issue":"11","key":"1947_CR1","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.5588\/ijtld.14.0120","volume":"18","author":"SK Brode","year":"2014","unstructured":"Brode SK, Daley CL, Marras TK. The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review. Int J Tuberc Lung Dis. 2014;18(11):1370\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"1947_CR2","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3201\/eid2206.151086","volume":"22","author":"H Namkoong","year":"2016","unstructured":"Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, et al. Epidemiology of pulmonary nontuberculous mycobacterial disease. Jpn Emerg Infect Dis. 2016;22(6):1116\u20137.","journal-title":"Jpn Emerg Infect Dis"},{"issue":"10","key":"1947_CR3","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jiac.2018.06.014","volume":"24","author":"N Urabe","year":"2018","unstructured":"Urabe N, Sakamoto S, Sano G, Ito A, Homma S. Characteristics of patients with bronchoscopy-diagnosed pulmonary Mycobacterium avium complex infection. J Infect Chemother. 2018;24(10):822\u20137.","journal-title":"J Infect Chemother"},{"issue":"1","key":"1947_CR4","doi-asserted-by":"publisher","first-page":"e000050","DOI":"10.1136\/bmjresp-2014-000050","volume":"1","author":"K Fujita","year":"2014","unstructured":"Fujita K, Ito Y, Hirai T, Kubo T, Togashi K, Ichiyama S, et al. Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease. BMJ Open Respir Res. 2014;1(1):e000050.","journal-title":"BMJ Open Respir Res"},{"issue":"1","key":"1947_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12890-017-0544-x","volume":"17","author":"H Kamata","year":"2017","unstructured":"Kamata H, Asakura T, Suzuki S, Namkoong H, Yagi K, Funatsu Y, et al. Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease. BMC Pulm Med. 2017;17(1):198.","journal-title":"BMC Pulm Med"},{"issue":"4","key":"1947_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1947_CR7","doi-asserted-by":"publisher","first-page":"1800170","DOI":"10.1183\/13993003.00170-2018","volume":"51","author":"J Van Ingen","year":"2018","unstructured":"Van Ingen J, Aksamit T, Andrejak C, B\u00f6ttger EC, Cambau E, Daley CL, et al. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. Eur Respir J. 2018;51(3):1800170.","journal-title":"Eur Respir J"},{"key":"1947_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-2466-11-42","volume":"11","author":"PW Jones","year":"2011","unstructured":"Jones PW, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT\u2122) scores. BMC Pulm Med. 2011;11:42.","journal-title":"BMC Pulm Med"},{"issue":"5","key":"1947_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2169\/internalmedicine.53.1277","volume":"53","author":"K Morimoto","year":"2014","unstructured":"Morimoto K, Yoshiyama T, Kurashima A, Sasaki Y, Hoshino Y, Yoshimori K, et al. Nutritional indicators are correlated with the radiological severity score in patients with Mycobacterium avium complex pulmonary disease: a cross-sectional study. Intern Med. 2014;53(5):397\u2013401.","journal-title":"Intern Med"},{"issue":"4","key":"1947_CR10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1128\/jcm.6.4.396-399.1977","volume":"6","author":"RW Geckler","year":"1977","unstructured":"Geckler RW, Gremillion DH, McAllister CK, Ellenbogen C. Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates. J Clin Microbiol. 1977;6(4):396\u20139.","journal-title":"J Clin Microbiol"},{"issue":"6 Pt 1","key":"1947_CR11","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1164\/ajrccm.153.6.8665032","volume":"153","author":"RJ Wallace Jr","year":"1996","unstructured":"Wallace RJ Jr, Brown BA, Griffith DE, Girard WM, Murphy DT. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. Am J Respir Crit Care Med. 1996;153(6 Pt 1):1766\u201372.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1947_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1086\/313644","volume":"30","author":"DE Griffith","year":"2000","unstructured":"Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ Jr. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex. Clin Infect Dis. 2000;30(2):288\u201392.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1947_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1164\/rccm.201408-1545OC","volume":"191","author":"BH Jeong","year":"2015","unstructured":"Jeong BH, Jeon K, Park HY, Kim SY, Lee KS, Huh HJ, et al. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2015;191(1):96\u2013103.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1947_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1513\/AnnalsATS.201308-266OC","volume":"11","author":"S Miwa","year":"2014","unstructured":"Miwa S, Shirai M, Toyoshima M, Shirai T, Yasuda K, Yokomura K, et al. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study. Ann Am Thorac Soc. 2014;11(1):23\u20139.","journal-title":"Ann Am Thorac Soc"},{"key":"1947_CR15","doi-asserted-by":"publisher","first-page":"106025","DOI":"10.1016\/j.rmed.2020.106025","volume":"69","author":"Y Ito","year":"2020","unstructured":"Ito Y, Miwa S, Shirai M, Kanai M, Fujita K, Ohba H, et al. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy. Respir Med. 2020;69:106025.","journal-title":"Respir Med"},{"issue":"7","key":"1947_CR16","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1164\/rccm.201307-1200OC","volume":"188","author":"AM Binder","year":"2013","unstructured":"Binder AM, Adjemian J, Olivier KN, Prevots DR. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. Am J Respir Crit Care Med. 2013;188(7):807\u201312.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1947_CR17","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","volume":"151","author":"TR Aksamit","year":"2017","unstructured":"Aksamit TR, O\u2019Donnell AE, Barker A, Olivier KN, Winthrop KL, Daniels MLA, et al. Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry. Chest. 2017;151(5):982\u201392.","journal-title":"Chest"},{"issue":"5","key":"1947_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","volume":"189","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576\u201385.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1947_CR19","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.2214\/AJR.07.3505","volume":"191","author":"JW Song","year":"2008","unstructured":"Song JW, Koh WJ, Lee KS, Lee JY, Chung MJ, Kim TS, et al. High-resolution CT findings of Mycobacterium avium-intracellulare complex pulmonary disease: correlation with pulmonary function test results. AJR Am J Roentgenol. 2008;191(4):W160.","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"1947_CR20","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1378\/chest.12-0494","volume":"142","author":"WJ Koh","year":"2012","unstructured":"Koh WJ, Jeong BH, Jeon K, Lee NY, Lee KS, Woo SY, et al. Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M. avium complex lung disease. Chest. 2012;142(6):1482\u20138.","journal-title":"Chest"},{"key":"1947_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2016.05.001","volume":"116","author":"K Dimakou","year":"2016","unstructured":"Dimakou K, Triantafillidou C, Toumbis M, Tsikritsaki K, Malagari K, Bakakos P. Non CF-bronchiectasis: aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients. Respir Med. 2016;116:1\u20137.","journal-title":"Respir Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-01947-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-022-01947-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-01947-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T10:05:52Z","timestamp":1650881152000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-022-01947-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1947"],"URL":"https:\/\/doi.org\/10.1186\/s12890-022-01947-7","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"assertion":[{"value":"12 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the amended Declaration of Helsinki and the Ethics Committee of Toho University Omori Medical Center approved the protocol (Approval No. M21218). All methods were carried out in accordance with relevant guidelines and regulations. All patients provided written informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}